CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Myriad Genetics Inc Company Snapshot
Myriad Genetics Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Myriad Genetics Inc with three other companies in this sector in the United States: Amag Pharmaceuticals Incorporation (2016 sales of $532.09 million of which 100% was License fees), Meridian Bioscience, Inc. ($196.08 million of which 74% was US Diagnostics), and Neogen Corporation ($321.28 million of which 55% was Animal Safety).

Sales Analysis. Myriad Genetics Inc reported sales of $753.80 million for the fiscal year ending June of 2016. This represents an increase of 4.2% versus 2015, when the company's sales were $723.10 million. Despite this increase, sales are still below the level achieved in 2014, when Myriad Genetics Inc reported sales of $778.22 million. Sales of Others saw an increase that was more than double the company's growth rate: sales were up 74.3% in 2016, from $27.60 million to $48.10 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Myriad Genetics Inc
  Stock Performance Chart for Myriad Genetics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 21.08
(Figures in U.S. Dollars)
1 Week -4.8%   13 Weeks 19.7%  
4 Weeks 13.2%   52 Weeks -38.3%  
 
Myriad Genetics Inc Key Data:
  Ticker: MYGN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 753,800,000
(Year Ending Jan 2017).
Employees: 2,206
  Currency: U.S. Dollars Market Cap: 1,435,936,926
  Fiscal Yr Ends: June Shares Outstanding: 68,118,450
  Share Type: Common Closely Held Shares: 649,613
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.